N/A
N=8
Clinical Interviews With Detainees With Early Psychosis
First-Episode Psychosis
Bottom Line
View on ClinicalTrials.gov: NCT03962348 ↗Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcome: Primary: Number of Referrals to Correctional Health Services (CHS) — 8 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Specialized Early Engagement Support Service (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Columbia University
- Primary completion
- Mar 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Referrals to Correctional Health Services (CHS) |
8 | — |
| PRIMARY Number of Referrals to Coordinated Specialty Care (CSC) |
1 | — |
Summary
The investigators are studying a jail-based intervention to reduce the duration of untreated psychosis (DUP) among young adults with previously undetected first-episode psychosis who are detained in jail. Longer DUP (or treatment delay) is linked to poorer outcomes in first-episode psychosis and there is evidence that justice-involved young adults with first-episode psychosis have an alarmingly long DUP. Thus, despite the expansion of Coordinated Specialty Care (CSC) programs that improve outcomes through early, multi-component care, there is a need to establish early detection services in the criminal justice system and create pathways from justice involvement to CSC. This intervention offers a novel and potentially high impact approach for reducing DUP in jail settings: a jail-based Specialized Early Engagement Support Service that receives referrals, engages detainees, and serves as a bridge to community-based CSC. The study team will design and implement the intervention, thoroughly study its feasibility and acceptability, and prepare an intervention manual for broader use in diverse jails and future formal research.
Eligibility Criteria
Inclusion Criteria
- Detainees that have been referred by Correctional Health Services as experiencing early-course or first-episode psychosis
- between the ages of 18 and 30 years
- have a Mini-Mental State Examination (MMSE) score of >23
- have the capacity to provide informed consent for the study
- able to understand and speak English
Exclusion Criteria
- children under the age of 18 years
Data sourced from ClinicalTrials.gov (NCT03962348). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.